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Background and purpose — The use of a cemented cup together 
with an uncemented stem in total hip arthroplasty (THA) has 
become popular in Norway and Sweden during the last decade. 
The results of this prosthetic concept, reverse hybrid THA, have 
been sparsely described. The Nordic Arthroplasty Register Asso-
ciation (NARA) has already published 2 papers describing results 
of reverse hybrid THAs in different age groups. Based on data 
collected over 2 additional years, we wanted to perform in depth 
analyses of not only the reverse hybrid concept but also of the dif-
ferent cup/stem combinations used.
Patients and methods — From the NARA, we extracted data 
on reverse hybrid THAs from January 1, 2000 until December 31, 
2013. 38,415 such hips were studied and compared with cemented 
THAs. The Kaplan-Meier method and Cox regression analyses 
were used to estimate the prosthesis survival and the relative risk 
of revision. The main endpoint was revision for any reason. We 
also performed specifi c analyses regarding the different reasons 
for revision and analyses regarding the cup/stem combinations 
used in more than 500 cases.
Results — We found a higher rate of revision for reverse hybrids 
than for cemented THAs, with an adjusted relative risk of revision 
(RR) of 1.4 (95% CI: 1.3–1.5). At 10 years, the survival rate was 
94% (CI: 94–95) for cemented THAs and 92% (95% CI: 92–93) 
for reverse hybrids. The results for the reverse hybrid THAs were 
inferior to those for cemented THAs in patients aged 55 years or 
more (RR = 1.1, CI: 1.0–1.3; p < 0.05). We found a higher rate of 
early revision due to periprosthetic femoral fracture for reverse 
hybrids than for cemented THAs in patients aged 55 years or 
more (RR = 3.1, CI: 2.2–4.5; p < 0.001).
Interpretation — Reverse hybrid THAs had a slightly higher 
rate of revision than cemented THAs in patients aged 55 or more. 
The difference in survival was mainly caused by a higher inci-
dence of early revision due to periprosthetic femoral fracture in 
the reversed hybrid THAs.
■
The reverse hybrid THA is the combination of a cemented 
all-polyethylene cup and an uncemented stem. It has become 
popular in Norway and Sweden (Lindalen et al. 2011). Based 
on the fi ndings from the Norwegian Arthroplasty Register 
(NAR) in the 1990s with poorer results with uncemented cups 
than with cemented cups, and good long-term results for some 
uncemented stems in young patients, Havelin et al. (2000) 
suggested performing randomized trials to evaluate the effi -
cacy of cemented cups combined with uncemented stems in 
young patients.
McNally et al. (2000) reported more than 90% survival with 
a cemented cup/uncemented stem combination after 12 years. 
The reverse hybrid concept also found support in some Nordic 
registery studies, which demonstrated that in young patients 
some uncemented femoral stems could outperform some 
cemented stems, and that cemented cups could outperform 
uncemented metal-backed cups with UHMWPE that was not 
crosslinked (Havelin et al. 2002, Hallan et al. 2007, Hailer et 
al. 2010, Mäkelä et al. 2010).
In 2011, the NAR published results of 3,963 reverse hybrid 
THAs and found no improvement in implant survival com-
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pared to cemented THA at 5 and 7 years, regardless of age 
(Lindalen et al. 2011). The Nordic Arthroplasty Register Asso-
ciation (NARA) (Mäkelä et al. 2014) showed better results for 
cemented THAs than for reverse hybrid THAs in patients who 
were 65 years or older. In a study on patients younger than 55 
years from the same collaboration, a tendency was found of a 
lower revision rate for any reason with reverse hybrid THAs 
than with cemented THAs (Pedersen et al. 2014). 
In the present study, we compared the results of reverse 
hybrid THAs with those of cemented THAs based on larger 
numbers and a longer follow-up than previously published. 
We also wanted to perform detailed analyses regarding cup/
stem combinations of reverse hybrid THAs and to compare 
highly crosslinked and non- or low-crosslinked cups.
Patients and methods
The NARA was established in 2007 (Havelin 2011). It is a col-
laboration of the national arthroplasty registries of Denmark, 
Finland, Norway, and Sweden. Individual data on primary and 
revision THAs are collected in each country. A common THA 
dataset with anonymous data has been established. 496,567 
primary THAs were registered in the 4 national registries 
between January 1, 2000 and December 31, 2013. All primary 
cemented and reverse hybrid THAs operated during the period 
2000–2013 were included, regardless of the reason for hip 
replacement. Surface replacements and THAs with unknown 
or missing information on fi xation were excluded.
The diagnoses Calve-Legg-Perthes, slipped femoral capital 
epiphyses, and dysplasia were merged into 1 group named 
childhood hip disease. Patients with bilateral procedures were 
included, as earlier research has shown that this does not bias 
the results (Lie et al. 2004, Ranstam and Robertsson 2010).
We found 38,415 reverse hybrid THAs and 267,755 cemented 
THAs (Table 1).
In this study, we decided to use cemented THAs as com-
parator since this combination had the lowest overall revision 
rate for all age groups in the previous studies (Mäkelä et al. 
2014; Pedersen et al. 2014).
We analyzed the results for the 2 modes of fi xation in gen-
eral and in 4 age groups (< 55, 55–64, 65–74, and > 74 years) 
and we studied the assessed relative risks of revision caused 
by fracture, infection, loosening, and dislocation. We also per-
formed separate analyses of males and females regarding peri-
prosthetic fractures. Furthermore, we studied the infl uence of 
death as a possible competing risk for revision.
35 stem and cup combinations had each been used in more 
than 100 cases. 9 combinations had been used in more than 
500 cases. These 9 combinations were studied more closely 
with Cox analyses for 3 different follow-up periods (0–1, 1–5, 
and > 5 years) with adjustments for age, sex, and diagnosis. 
Cemented THAs were used as a reference (Figure 1).
Highly crosslinked all-polyethylene cups were introduced 
onto the Nordic market during the study period. The infl uence 
of this potential confounder was studied in separate analyses. 
Lastly, we looked at the infl uence of head size and bearing 
materials on the overall results. 
Statistics
The endpoint in the analyses was implant revision, mean-
ing the exchange or removal of either the whole THA or any 
Table 1. Demographic data for cemented and reverse hybrid THAs. 
Comparison of survival (in %) and relative risk (RR) of revision, with 
all revisions as endpoint for the total material
 Cemented Reverse hybrid
 n = 267,755 n = 38,415
Revisions 9,975 1,426
Median follow-up (IQR) 6.2 (3.2–9.3) 3.3 (1.6–5.9)
Median age (IQR)  73 (67–79) 64 (57–72)
% Men 35 40
Deceased 65,379 2,242
Diagnosis, %
 Osteoarthritis 81.0 79.0
 RA/infl ammatory   2.5   2.5
 Sequelae hip fracture   11.2   8.0
 Childhood disease   1.7   6.4
    Femoral head necrosis     2.2   2.4
    Others   1.3   1.5
5-year survival, % 97 (97–97) 96 (96–96)   
   number at risk 55,864 11,717
10-year survival, % 95 (94–95) 92 (92–93)
   number at risk 52,477   2,045
RR a  (95% CI) 1 (Reference) 1.4 (1.3–1.5)
a Adjusted for age, sex, period, and diagnosis
IQR: interquartile range. Figure 1. Flow chart of the study.
Nordic Arthroplasty Register Association




Reverse hybrid implant combinations




– Reﬂection all poly/Corail,  1,657
– Contemporary/Corail,  1,396
– Titan/Corail, 904
– Contemporary/ABGII HA, 646
– Kronos/Corail, 632
– Lubinus/Spotorno,  515
Different combinations
of reverse hybrid THA
used in < 500 cases
n = 16,836  
Cemented THA
n = 267,755
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part of it. To estimate the survival of the THAs, we used the 
Kaplan-Meier method with 95% confi dence interval (CI). 
We stopped calculating survival probabilities when less than 
20 hips remained at risk. The follow-up time was calculated 
from primary operation until implant revision or the patient 
was censored at the end of the study (December 31, 2013), 
at death, or emigration. To calculate median follow-up time, 
we used the reverse Kaplan-Meier method. The relative risk 
of revision (RR) were estimated (with 95% CI) by using Cox 
regression analyses with adjustments for age (< 55, 55–64, 
65–74, and > 74 years), sex, diagnosis, and time period. We 
considered p-values of less than 0.05 to be statistically sig-
nifi cant. To investigate death as a possible competing risk for 
revision, we performed a competing-risk analysis (Fine and 
Gray 1999). For statistical analysis, we used SPSS version 
22.0 and the R statistical software package version 3.2.1.
Results
The median length of follow-up was 6 years for the cemented 
THAs and 3 years for the reverse hybrid THAs. Mean age 
at the time of surgery for the reverse hybrid THAs was 64 
years, as compared to 73 years for cemented THAs (Table 1). 
There was a higher proportion of males in the reverse hybrid 
group (40%) than in the cemented group (35%) (Table 1). The 
implant survival of the cemented THAs was 97% (CI: 97–97) 
at 5 years, as opposed to 96% (CI: 96–96) for reverse hybrid 
THAs, using any reason for revision as endpoint. At 10 years, 
implant survival was 95% (CI: 94–95) for cemented THAs 
and 92% (CI: 92–93) for reverse hybrid THAs (Table 1).
After adjustment for sex, age, diagnosis, and time period, 
reverse hybrid THAs had a relative risk of revision of 1.4 (CI: 
1.3–1.5; p < 0.001) (Figure 2) compared to cemented THAs. 
When stratifying for time period and age groups, the results 
did not change when accounting for death as a competing risk.
Aseptic loosening, deep infection, and dislocation were the 
3 most frequent causes of revision for both reverse hybrid 
THA and cemented THA (36% vs. 41%, 22% vs. 20%, 15% 
vs. 26%, respectively, expressed as percentage of all causes of 
revision with each concept).
The relative risk of revision for loosening was higher in 
reverse hybrids in patients aged ≥ 65 years (RR = 1.6, CI: 1.4–
2.0; p < 0.001). We were not able to analyze separate results 
for loosening of the cups and stems, since the data from the 
NARA do not differentiate between revisions of different parts 
of the prosthesis.
There was no statistically signifi cant difference in the risk 
of revision for infection in the younger patient groups. For 
patients older than 74 years with a reverse hybrid THA, there 
was a 1.7 times (CI: 1.3–2.1; p < 0.001) higher risk of revision 
due to infection. We found no signifi cant difference in the risk 
of revision due to dislocation.
During the fi rst year after the index operation, the risk of 
revision in patients younger than 55 years was similar between 
reverse hybrid and cemented THAs. From the age of 55 years, 
those with reverse hybrid THA had a higher risk of early revi-
sion than those in the corresponding age group with cemented 
THAs (Figure 3). 
Reverse hybrid THAs were associated with an elevated risk 
of revision due to periprosthetic fracture in all age groups 
except those less than 55 years old. The relative risk increased 
with age from 3 in patients 55–64 years of age to 6 in patients 
aged > 74 years (Table 2). The highest increase was observed 
in women over 74 years old when compared to cemented 
implants in the corresponding age group (RR = 8, CI: 5–12; p 
< 0.001) (Table 3). Of all the fractures reported (n = 878), two-
thirds were reported within the fi rst year after surgery. 
Figure 2. Cox survival analysis with adjust-
ment for age, sex, time period, and diagnosis, 
and with any revision of the implant as end-
point. RR = 1.4 (CI: 1.3–1.5; p < 0.001).
Cemented
Reverse hybrid

















Figure 3. Revisions in the fi rst 12 months after 
surgery. Cox survival analysis with adjustment 
for sex, diagnosis, and period.








Figure 4. Prosthesis survival with revision of 
either cup or stem for any reason, and with 
adjustment for sex, age, diagnosis, and period.
Cemented, < 55 years
Cemented, 55–64 years
Cemented, 65–74 years
Cemented, > 74 years
Reverse hybrid, < 55 years
Reverse hybrid, 55–64 years
Reverse hybrid, 65–74 years
Reverse hybrid, > 74 years
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9 different cup/stem combinations in reverse hybrids were 
studied in detail (those that had each been used in more than 
500 cases) (Figure 4 and Table 4). We found no signifi cant 
difference in survival for 7 out of the 9 different combinations 
studied compared to cemented THAs. The combination Mara-
thon cup/Corail stem, which also had the shortest follow-up, 
showed an increased risk of revision when compared to the 
entire group of cemented implants (RR = 1.3, CI: 1.2–1.5; p 
< 0.001).
Studies of different time periods showed that 6 reverse 
hybrid implant combinations had a higher risk of revision 
than cemented THAs in the fi rst period (0–1 year of follow-
up) (Table 5). In the third period (> 5 years of follow-up), 
which included 6 combinations, the Elite/Corail combination 
had a lower risk of revision than cemented THAs (RR = 0.4, 
CI: 0.2–0.7; p = 0.02) whereas Refl ection all-poly/Corail had 
a higher risk of revision (RR = 2.0, CI: 1.4–3.1; p < 0.001) 
(Table 6).
Different head sizes and different bearing materials did not 
affect the results signifi cantly.
Because of low numbers during the fi rst years of the study 
period, we were only able to compare the results for the highly 
crosslinked and the non- or low-crosslinked all-poly cups from 
2004–2013. We found similar survival for the 2 different cups.
Discussion
We found that reverse hybrid THA had a slightly higher rate 
of revision than all-cemented THAs at 10-year follow-up. The 
main reason was a higher number of early revisions, espe-
cially due to periprosthetic femoral fractures in reverse hybrid 
THAs used in elderly patients.
Reverse hybrid THA has been used on a regular basis since 
the year 2000 in Norway, and reached a proportion of one-
Table 2. Comparison of reverse hybrid THAs and 
cemented THAs in corresponding age groups 
regarding risk of revision. Cemented THAs were 
defi ned as 1 when calculating RR. Cox analysis 
was used, with adjustment for gender, primary 
diagnosis, and period
Age group RR a CI (95%) p-value
< 55 years
 All revisions 0.9 0.8–1.0 0.07
 Fracture 1.4 0.8–2.5 0.3
 Infection 0.7 0.5–1.1 0.08
 Loosening 0.9 0.7–1.1 0.2
 Dislocation 0.8 0.5–1.1 0.2
55–64 years    
 All revisions 1.1 1.0–1.3 0.013
 Fracture 3.1 2.2–4.5 <0.001
 Infection 1.1 0.8–1.4 0.7
 Loosening 1.1 0.9–1.3 0.5
 Dislocation 0.8 0.6–1.0 0.1
65–74 years    
 All revisions 1.5 1.3–1.7 <0.001
 Fracture 4.0 2.9–5.3 <0.001
 Infection 1.1 0.9–1.3 0.6
 Loosening 1.6 1.4–2.0 <0.001
 Dislocation 0.8 0.6–1.0 0.08
> 74 years    
 All revisions 2.0 1.8–2.3 <0.001
 Fracture 5.8 4.3–7.9 <0.001
 Infection 1.7 1.3–2.1 <0.001
 Loosening 2.6 2.0–3.5 <0.001
 Dislocation 1.2 0.9–1.6 0.2
a Cemented THA same age group = 1
Table 3. Relative risk of revision due to fracture in men and women
 Men Women
  RR a   95% CI p-value RR a   95% CI p-value
< 55 1.4 0.5–3.4 0.5 1.4 0.6–3.0 0.4
55–64  2.1 1.2–3.5 0.006 4.9 2.9–8.3 < 0.001
65–74 2.1 1.3–3.4 0.004 6.7 4.5–9.9 < 0.001
> 74  3.5 2.0–6.0 < 0.001 7.9 5.4–11.5 < 0.001
a Cemented THA same age group = 1, with adjustment for diagnosis 
and period.
Table 4. Cox regression results for reverse hybrid brand combinations compared to 
cemented THAs, with adjustment for age, sex, period, and diagnosis. The endpoint 
was any revision. Median follow-up was calculated by “reverse Kaplan-Meier”
       Median
  Total Revised    follow-up
Prosthesis cup/stem n n  RR 95% CI p-value  (IQR)
Cemented THA 267,755 9,975 1   6.2 (3.2–9.3)
Elite/Corail     3,346 107 0.8 0.7–1.0 0.05 5.3 (3.5–6.8)
Titan/Corail        904 45 1.2 0.9–1.7 0.2 5.6 (4.1–8.6)
Kronos/Corail        632 22 0.9 0.6–1.3 0.5 5.5 (4.3–6.9)
Refl ection all-poly/Corail  1,183 60 1.3 1.0–1.7 0.05 5.2 (4.1–7.2)
Contemporary/Corail        902 20 0.7 0.5–1.1 0.1 4.0 (2.9–5.2)
Marathon/Corail     8,856 202 1.3 1.2–1.5 < 0.001 1.6 (0.8–2.6)
Lubinus/Spotorno        515 10 0.6 0.3–1.0 0.06 5.1 (3.1–6.3)
Lubinus/Corail     1,932 54  1.2 0.9–1.5 0.3 3.1 (1.8–4.3)
Contemporary/ABG II HA 646 32 1.4 1.0–1.9 0.08 5.0 (3.9–6.8)
IQR: interquartile range. 
Table 5. Cox regression results for reverse hybrid brand combina-
tions compared to cemented THAs concerning early revision (< 1 
year), with adjustment for age, sex, period, and diagnosis
  Total Revised   
Prosthesis cup/stem n n  RR 95% CI p-value
Cemented THA 267,755 3,038 1
Elite/Corail     3,346 56 1.5 1.2–2.0 0.002
Titan/Corail        904 26 2.8 1.9–4.1 < 0.001
Kronos/Corail        632 13 1.8 1.0–3.1 0.04
Refl ection all-poly/Corail     1,183 18 1.4 0.9–2.3 0.1
Contemporary/Corail        902 10 0.9 0.5–1.7 0.8
Marathon/Corail     8,856 172 1.8 1.5–2.1 < 0.001
Lubinus/Spotorno        515 5 0.9 0.4–2.3 0.9
Lubinus/Corail     1,932 43  1.8 1.4–2.5 < 0.001
Contemporary/ABG II HA       646 12 2.0 1.1–3.5 0.01
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third of all primary THAs implanted in the year 2011 (Nor-
wegian Arthroplasty Register Annual Report 2012). The pro-
portion in Sweden was 13% for the same year (Swedish Hip 
Arthroplasty Register Annual Report 2012). In Finland and 
Denmark, reverse hybrid is an uncommonly used concept, 
with only 861 in Denmark and 3,022 in Finland during the 
study period.
McNally et al. (2000) published very good results for the 
Furlong stem together with a cemented ultra-high-density 
polyethylene cup at 10–11 years, with 99% survival for the 
stem and 95% for the cup. Lindalen et al. (2011) found equal 
survival of reverse hybrid THAs and cemented THAs at 5 
years and 7 years (cemented: 97.0% and 96.0%, respectively; 
reverse hybrid: 96.7% and 95.7%) whereas we found higher 
survival rates with use of all-cemented THAs at 5 and 10 
years. This difference can be explained by the lower number 
of implants studied by Lindalen et al., the higher mean age 
in our study (63 vs. 61 years), and the fact that our follow-up 
was longer.
Inclusion of 2 more years did not change the overall con-
clusion that we came to in previous studies on reverse hybrid 
THAs, with similar 10-year survival for reverse hybrid and 
cemented THAs in patients between 55 and 65 years of age. In 
patients aged 65 years or more, however, the 10-year survival 
of the cemented implants was higher than that of the reverse 
hybrids (Mäkelä et al. 2014, Pedersen et al. 2014).
To study the effect of age on implant survival, we compared 
the 2 types of fi xations in different age groups. The main fi nd-
ings were a 4 times higher risk of periprosthetic femoral frac-
ture in patients with reverse hybrid THAs who were 65 years 
old or more, which increased to almost 6 times higher risk 
in patients over 74 years old. Periprosthetic femoral fractures 
are seen more often when using uncemented stems, especially 
during the fi rst 6 months after surgery (Thien et al. 2014). In 
our study, two-thirds of the fractures were seen during the fi rst 
12 months after surgery. Fractures during surgery might occur 
either during broaching or when inserting the stem; to achieve 
primary stability of the implant, the broaching must be more 
aggressive than when using cement. In older patients, the bone 
is more fragile and the risk of cracks and fractures is therefore 
higher. On the other hand, cement reinforces the weak bone, 
making a stronger construct.
Swedish Hip Arthroplasty Register (Annual Report 2013), 
periprosthetic femoral fractures might be under-reported—
and especially those fractures that are treated only with inter-
nal fi xation. We do, however, believe that this possible source 
of error would be distributed equally between cemented and 
reverse hybrid THAs.
We found no difference in the rate of revision due to deep 
infection between cemented and reverse hybrid THAs except 
in patients over 74 years, who had double the risk of revision. 
In a previous study from the NARA covering THAs operated 
until 2009, Dale et al. (2012) found no difference in the rela-
tive risk of revision due to infection between reverse hybrid 
and cemented THAs in general. Our fi ndings in the oldest 
patients can be explained by the fact that there is often a cor-
relation between higher age and a higher rate of comorbidity, 
and therefore a higher risk of infection. Later on, our data-
set included also cases operated until 2013, which may have 
infl uenced the results. Antibiotic-loaded cement is believed to 
protect against infection (Dale et al. 2012), and since the stem 
is uncemented there might be a higher risk of infections in 
susceptible patients.
According to the National Joint Replacement Registry of 
Australia (2013), uncemented THAs have more early revisions 
than cemented ones, but from 8 years onwards the survival of 
uncemented THAs was better than that of cemented THAs.
In young patients, Havelin et al. (2000) found better per-
formance of some uncemented stems than of cemented stems 
in the NAR, mainly because of less aseptic loosening. Hallan 
et al. (2007) showed in another study that included younger 
patients than those studied by us, that all uncemented stems 
that were frequently used at that time had a 10-year survival 
of more than 96% with this endpoint. It might be that our 
follow-up has been too short to show any benefi ts of the unce-
mented stems in reverse hybrid THAs. Since the data from the 
NARA do not distinguish between loosening of the stem and 
the cup, one should be careful when making any conclusions 
on this issue. Despite this, we believe that the higher incidence 
of aseptic loosening in patients aged 65 years or more could 
be related to inadequate primary fi xation of the uncemented 
stems.
Since the Corail stem was used in most of the cup/stem 
combinations studied, differences in survival can most prob-
Table 6. Cox regression results for reverse hybrid brand combinations compared to cemented 
THAs with follow-up of more than 5 years, and with adjustment for age, sex, and diagnosis
  Total Revised    At 8 years At 10 years
Prosthesis cup/stem n n  RR 95% CI p-value n n
Cemented THA 155,845 2,825 1   90,886 52,447
Elite/Corail     1,818 11 0.4 0.2–0.7 0.02 426 168
Titan/Corail        499 7 0.6 0.3–1.3 0.2 239 107
Kronos/Corail        369 2 0.3 0.1–1.4 0.1 74 30
Refl ection all-poly/Corail     628 25 2.0 1.4–3.1 < 0.001 217 88
Contemporary/ABG II HA 311 2 0.5 0.1–1.8 0.3 51 –
Reverse hybrid implant, female 
sex, and age over 74 years was the 
worst combination regarding the risk 
of periprosthetic femoral fractures. 
For women in general, the bone starts 
to become more fragile at an earlier 
age than for men and osteoporosis 
is more common in women than in 
men. We believe that this could be the 
main reason for the higher incidence 
of periprosthetic femoral fractures in 
this patient group. According to the 
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ably be explained by differences on the acetabular side. There 
was no statistically signifi cant difference in survival when we 
compared the different combinations to all-cemented THAs 
for the entire period studied, except for one combination: 
Marathon/Corail. The median age of Marathon/Corail patients 
was 68 (60–78) years, as compared to 64 (57–72) years for all 
reverse hybrids. This might explain some of the difference, 
since age is one of the risk factors—especially for early revi-
sion in reverse hybrid THA. This is also supported by the fi nd-
ings when studying results for different time periods. Mara-
thon/Corail had inferior results to those of cemented THAs 
only in the fi rst postoperative period studied. Looking at the 
period 1–5 years post operatively, Corail/Marathon performed 
as well as cemented THAs. 
In the fi rst postoperative period (0–1 year of follow-up), all 
reverse hybrid combinations performed worse than cemented 
THAs except for 3 combinations: Refl ection all-poly/Corail, 
Contemporary/Corail, and Lubinus/Spotorno. In the second 
period (1–5 years), we found no difference in survival between 
the different combinations of reverse hybrid THAs and 
cemented THAs. This confi rms the fact that the poorer result 
with reverse hybrid THAs is mainly related to a higher rate of 
revisions within the fi rst year after surgery. In the third period 
studied (> 5 years of follow-up), there was a trend showing 
better results for reverse hybrids than for cemented THA, but 
only the Elite/Corail combination performed statistically sig-
nifi cantly better. The Refl ection all-poly/Corail combination 
had inferior results to all other combinations after 5 years of 
follow-up. We believe that this was due to inferior long-term 
results for the Refl ection all-poly cups with conventional poly-
ethylene. Espehaug et al. (2009) published results for this cup 
in 2009 showing that it was inferior, and a later RSA study has 
shown high wear rates (Kadar et al. 2011).
The implant survival was not improved by the use of highly 
crosslinked polyethylene. This is different from what is 
reported in the annual report of the Australian Orthopaedic 
Association National Joint Replacement Registry (2013). It 
was found that crosslinking of liners for uncemented modular 
cups improved the medium-term results compared to conven-
tional PE. Our follow-up was probably too short to show any 
difference. Furthermore, cemented cups may be less vulner-
able to wear-related problems than uncemented ones (Clement 
et al. 2011).
That study was based on data from the NARA, but since 
reverse hybrid THA is mainly used in Norway and Sweden 
only, the study refl ects the results mainly from 2 of the 4 
countries in the NARA. This is a weakness of our study, and 
refl ects one problem when combining databases from differ-
ent countries. Another weakness is the fact that the same stem 
(Corail) was used in most of the reverse hybrid THAs.
The main conclusions from this study are as follows. (1) 
Reverse hybrid THA had inferior implant survival than 
cemented THA in patients aged 65 years or more, because the 
fi rst concept entails a higher risk of early revision for peri-
prosthetic femoral fracture in this age group, and especially in 
women. (2) In patients younger than 65 years, reverse hybrid 
THAs and all-cemented THAs were equally good options. (3) 
According to the results of this study, the increasing use of 
reverse hybrid THAs in elderly patients (at least 65 years of 
age) does not appear to be justifi ed because of a higher rate of 
early postoperative complications.
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